首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1729624

日本手術縫線市場規模、佔有率、趨勢及預測（按類型、線材、應用、最終用途和地區），2025 年至 2033 年

Japan Surgical Sutures Market Size, Share, Trends and Forecasts by Type, Filament, Application, End Use, and Region, 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本手術縫線市場規模價值 3.19 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 5.53 億美元，2025 年至 2033 年的複合年成長率為 6.30%。人口老化、外科手術增加以及慢性病病例增加推動了市場的發展。此外，人們對可吸收縫線和精密手術技術的日益青睞也促進了市場的成長。政府支持、醫療基礎設施擴張以及醫療支出的增加進一步促進了日本手術縫合線市場佔有率的成長。

日本手術縫合線市場的主要驅動力是人口老化和慢性病發病率上升導致手術普及率上升。日本老年人口已達到前所未有的3,625萬人，佔總人口的29.3%，這一比例為全球最高。其中，女性2053萬人，男性1572萬人。此外，去年有 914 萬名老年人就業。日本人口連續13年呈現下降趨勢，預測2040年，老齡人口將佔日本總人口的34.8%。日本是世界上預期壽命最高的國家之一，導致老齡人口不斷成長，需要透過手術干預治療心血管疾病、骨科疾病和癌症等疾病。根據日本手術縫合線市場研究報告，微創手術技術的進步正在推動對高品質縫合線的需求，以增強傷口癒合並縮短恢復時間。此外，政府支持醫療基礎設施發展和技術創新的措施確保了人們能夠獲得先進的醫療產品，進一步促進了市場擴張。

此外，人們越來越傾向於採用可吸收縫線來改善患者的治療效果並減少術後併發症。人們對精準手術和機器人輔助手術的日益關注，也增加了對具有優異抗張強度和生物相容性的縫合線的需求。根據日本手術縫線市場分析，不斷上漲的醫療支出和支持先進外科手術的報銷政策鼓勵醫院和診所投資高性能縫線。日本的醫療福利產業目前是第三大產業，預計到 2035 年至 2040 年將成為第一大產業。預測顯示，到 2040 年，醫療保健支出將增至 89 兆日圓（約 6,000 億美元），比 2023 年的水準增加 1.6 倍。如果稅率保持穩定，這種情況可能會導致 27 兆日圓（約 1,800 億美元）的資金缺口。此外，主要市場參與者的存在以及旨在增強縫合材料和塗層的持續研發努力進一步促進了日本手術縫合線市場的成長。

日本手術縫合線市場趨勢：

擴大採用可生物分解和抗菌縫合線

日本手術縫合線市場的一個重要趨勢是人們對可生物分解和抗菌縫合線的偏好日益成長。可生物分解縫合線，特別是由聚乙醇酸和聚乳酸製成的縫合線，因其能夠自然溶解、無需拆線並降低感染風險而受到關注。此外，由於人們對手術部位感染（SSI）的擔憂日益增加，用於防止傷口部位細菌定植的抗菌塗層縫線的需求也增加。日本手術後手術部位感染（SSI）的總發生率為 4.2%。相較之下，涉及腸道（以共生菌濃度高而聞名）的胃腸手術的發生率僅為 7.2%。隨著醫療保健提供者強調患者安全和術後結果，製造商正專注於開發具有增強抗菌性能和生物相容性的縫線。這一趨勢推動了縫合材料和塗層的創新，進一步加強了日本手術縫合線的市場佔有率。

智慧縫合線和奈米技術整合的進展

智慧縫合線和奈米技術與手術縫合線的結合正在徹底改變日本市場。嵌入感測器的智慧縫合線可透過檢測感染、pH 值變化和組織壓力來即時監測傷口癒合。這些縫合線提供了重要的見解，有助於早期診斷和及時醫療干預，提高患者的康復率。此外，具有藥物洗脫特性的奈米技術增強縫合線因其能夠進行局部治療、減少發炎和增強組織再生的能力而越來越受歡迎。隨著日本在醫療技術進步方面繼續保持領先地位，對下一代縫線研發的投資正在增加，從而促進了創新並改善了各個醫學專業的手術效果。 2024 年 8 月 6 日，Shinobi Therapeutics 從日本醫療研究發展機構 (AMED) 獲得 5,900 萬美元的資助，用於進一步開發針對 GPC3+ 實體瘤的 iPS-T 細胞療法。此次融資使該公司的總融資額增加至 1.19 億美元，並增加了新投資者 Yosemite 和三菱 UFJ Capital。

機器人輔助和微創手術的需求不斷成長

機器人輔助和微創手術技術的日益普及是日本手術縫線市場的重要趨勢之一。 2024年5月9日，索尼打造了一款具有自動器械交換和精確控制功能的微手術輔助機器人，計劃於橫濱舉行的ICRA2024上亮相。這項創新旨在透過模仿涉及靜脈和神經的複雜手術的手部動作來解決日本外科醫生短缺的問題。在 2024 年 2 月於愛知醫科大學進行的一項試驗中，該機器人成功實施了世界上第一例利用自動器械交換的微血管吻合術，取得了重要的里程碑。外科醫生擴大利用機器人系統進行精密手術，這需要使用具有優異抗張強度和靈活性的專用縫線。微創手術需要較小的切口，這增加了對微型和倒鉤縫合線的需求，因為這些縫合線能夠以最小的組織創傷實現安全的傷口閉合。此外，由於醫院和外科中心優先考慮效率和縮短恢復時間，製造商正在開發適合腹腔鏡和機器人手術的縫線。隨著日本醫療保健產業採用先進的外科手術技術，預計這一趨勢將持續下去，從而為日本外科縫線市場帶來積極的前景。

The Japan surgical sutures market size was valued at USD 319 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 553 Million by 2033, exhibiting a CAGR of 6.30% from 2025-2033. The market is driven by an aging population, increasing surgical procedures, and rising cases of chronic diseases. Additionally, the growing preference for absorbable sutures and precision surgical techniques is enhancing market growth. Government support, healthcare infrastructure expansion, and rising healthcare expenditures further contribute to the Japan surgical sutures market share.

The Japan surgical sutures market is primarily driven by the rising prevalence of surgical procedures due to an aging population and increasing incidences of chronic diseases. Japan's senior demographic has attained an unprecedented figure of 36.25 Million, constituting 29.3% of the overall population, which is the highest percentage in the world. Of this group, 20.53 Million are women and 15.72 Million are men. Additionally, last year saw 9.14 Million seniors engaged in the workforce. Following a trend of population decline for 13 consecutive years, forecasts suggest that by 2040, the elderly will represent 34.8% of Japan's total population. Japan has one of the world's highest life expectancies, leading to a growing elderly demographic that requires surgical interventions for conditions such as cardiovascular diseases, orthopedic disorders, and cancer. According to the Japan surgical sutures market research report, advancements in minimally invasive surgical techniques are fueling demand for high-quality sutures that enhance wound healing and reduce recovery time. Moreover, government initiatives supporting healthcare infrastructure development and technological innovation further contribute to the market's expansion by ensuring access to advanced medical products.

In addition, the growing adoption of absorbable sutures is driven by the preference for improved patient outcomes and reduced post-operative complications. The increasing focus on precision surgery and robotic-assisted procedures is increasing the need for sutures with superior tensile strength and biocompatibility. According to the Japan surgical sutures market analysis, rising healthcare expenditures and reimbursement policies that support advanced surgical procedures encourage hospitals and clinics to invest in high-performance sutures. Japan's medical and welfare sector, currently the third largest industry, is anticipated to become the largest by the years 2035 to 2040. Projections indicate that healthcare expenditures will increase to ¥89 Trillion (approximately USD 600 Billion) by 2040, representing a 1.6-fold increase from the levels observed in 2023. Should tax rates remain stable, this situation may result in a funding deficit of ¥27 Trillion (around USD 180 Billion). Furthermore, the presence of key market players and continuous research and development efforts aimed at enhancing suture materials and coating further bolster Japan surgical sutures market growth.

Japan Surgical Sutures Market Trends:

Increasing Adoption of Biodegradable and Antimicrobial Sutures

A significant trend in the Japan surgical sutures market is the growing preference for biodegradable and antimicrobial sutures. Biodegradable sutures, particularly those made from polyglycolic acid and polylactic acid, are gaining attention due to their ability to dissolve naturally, avoiding the need for suture removal, and decreasing the risk of infection. Additionally, antimicrobial-coated sutures, designed to prevent bacterial colonization at the wound site, are witnessing increased demand in response to rising concerns about surgical site infections (SSIs). The general occurrence of surgical site infections (SSI) following operations in Japan stands at 4.2%. In contrast, the incidence rate for gastrointestinal surgeries that involve the intestinal tract, known for its high concentration of commensal bacteria, is recorded at 7.2%. With healthcare providers emphasizing patient safety and postoperative outcomes, manufacturers are focusing on developing sutures with enhanced antimicrobial properties and biocompatibility. This trend is driving innovation in suture materials and coatings, further strengthening the Japan surgical sutures market share.

Advancements in Smart Sutures and Nanotechnology Integration

The integration of smart sutures and nanotechnology into surgical sutures is revolutionizing the market in Japan. Smart sutures, embedded with sensors, offer real-time monitoring of wound healing by detecting infection, pH changes, and tissue stress. These sutures provide critical insights that help in early diagnosis and timely medical intervention, improving patient recovery rates. Additionally, nanotechnology-enhanced sutures with drug-eluting properties are gaining popularity for their ability to deliver localized treatment, reduce inflammation, and enhance tissue regeneration. As Japan continues to lead in medical technology advancements, investments in research and development for next-generation sutures are rising, fostering innovation and improving surgical outcomes across various medical specialties. On 6th August 2024, Shinobi Therapeutics obtained a grant of USD 59 million from Japan's Agency for Medical Research and Development (AMED) to further develop its iPS-T cell therapy targeting GPC3+ solid tumors. This funding increases the company's total financial backing to USD119 million, with the addition of new investors Yosemite and Mitsubishi UFJ Capital.

Growing Demand for Robotic-Assisted and Minimally Invasive Surgeries

The increasing adoption of robotic-assisted and minimally invasive surgical techniques is one of the significant Japan surgical sutures market trends. On 9th May 2024, Sony created a microsurgery assistance robot featuring automatic instrument exchange and precise control, scheduled to be unveiled at ICRA2024 in Yokohama. This innovation aims to tackle the shortage of surgeons in Japan by mimicking hand movements for intricate procedures involving veins and nerves. In a trial conducted in February 2024 at Aichi Medical University, the robot achieved a significant milestone by successfully executing the world's first microvascular anastomosis utilizing automated instrument exchange. Surgeons are increasingly utilizing robotic systems for precision-driven procedures, necessitating the use of specialized sutures with superior tensile strength and flexibility. Minimally invasive surgeries, which require smaller incisions, have heightened the demand for micro and barbed sutures that enable secure wound closure with minimal tissue trauma. Furthermore, as hospitals and surgical centers prioritize efficiency and reduced recovery times, manufacturers are developing sutures tailored for laparoscopic and robotic surgeries. This trend is expected to continue as Japan's healthcare sector embraces advanced surgical techniques, creating a positive Japan surgical sutures market outlook.

Japan Surgical Sutures Industry Segmentation:

Analysis by Type:

Absorbable
Nonabsorbable

Absorbable sutures are essential in the Japanese surgical sutures market, especially since they ensure fast healing of wounds and a reduced number of suture removals. They are made from synthetic polymers or natural materials such as catgut and dissolve inside the body after some time. Increasing usage in internal tissue repair, particularly in surgeries including gastrointestinal, gynecological, and orthopedic surgeries, has enhanced the demand in the market. Additionally, developments in suture coatings as well as antimicrobial properties make them a more effective option for the surgeons who focus on the reduction of infection risks and better recovery of patients.

Nonabsorbable sutures provide long-lasting tissue support. Therefore, the sutures come in handy with procedures that have a need to close wounds over a long duration, such as cardiovascular and orthopedic surgery. Unlike their absorbable varieties, they consist of materials that include nylon, polypropylene, and silk, which will not degrade once placed inside the body. Chronic disease-related surgeries have risen in Japan. Cardiovascular and neurosurgical applications are major growth areas. More importantly, novel technologies developed within the suture material enhance the performance, safety of wound closure, and patient outcomes from surgical procedures by decreasing complications, such as dehiscence in patients whose wound healing takes an extended time to occur.

Analysis by Filament:

Monovalent
Multivalent

Monofilament sutures consist of a single, smooth strand. Therefore, there is minimal bacterial contamination risk, and tissue trauma is minimized. The structure provides easy passage through tissues; they are especially handy for delicate procedures such as cardiovascular and plastic surgeries. The demand for monofilament sutures has increased as the demand for minimally invasive surgery has increased in Japan. Advance developments in suture materials, such as developments in absorbable and nonabsorbable substances with increased tensile strengths, add to this increase in popularity among surgeons looking for reliable, friction-reducing sutures that enhance wound healing with minimal tissue irritation.

Multifilament sutures comprise twisted or braided numerous strands put together, thereby yielding excellent flexibility, secure knots, and tensile strength. Such multifilament sutures are essential in relatively complex surgical procedures that require solid support to wounds, such as orthopedic and gastrointestinal surgeries. In Japan, the continually increasing rates of surgical procedures have led to an increased demand for multifilament sutures, especially in high-tension areas. However, since their braided structure can harbor bacteria, antimicrobial-coated variants are increasingly developed to minimize infection risks, ensuring their continued use in critical surgical applications requiring enhanced durability and stability.

Analysis by Application:

Ophthalmic Surgery
Cardiovascular Surgery
Orthopedic Surgery
Neurological Surgery
Others

Fine-gauge sutures in ophthalmic surgeries are used to minimize tissue damage and ensure speedy and effective healing. Improvement in the prevalence of cataracts, glaucoma, and retinal disorders in Japan will require more fine-gauge sutures particularly for delicate procedures in the eye. Monofilament and absorbable sutures are widely used to minimize scarring and promote recovery. The advancement in suture materials, including ultra-thin and biodegradable ones, improves surgical outcomes by reducing inflammation and promoting smooth tissue integration.

Cardiovascular surgeries require sutures that are very strong, biocompatible, and resistant to constant blood flow and tissue movement. In Japan, the incidence of heart diseases has risen, which has subsequently raised the use of durable and nonabsorbable sutures in valve replacement surgeries, and bypass surgeries. Monofilament sutures are preferred for reducing infection risks, while synthetic absorbable options provide temporary support. Innovations in coated sutures with enhanced tensile strength contribute to improved patient outcomes and long-term surgical success.

Orthopedic procedures require the use of sutures with good tensile strength to support the healing of the musculoskeletal system. Due to an aged population and sporting injuries, demands for strong sutures used to repair ligaments, reconstruct the joint, or fix bones, have increased over the years. Both absorbable and non-absorbable sutures are used based on the procedure. Advances in suture coatings and braided designs allow for increased security of knots for stable wound closure with minimal complications during healing.

Neurosurgical sutures must be highly precise and stable while minimizing tissue reaction. Brain and spinal surgery have been significantly on the rise in Japan, thus increasing the demand for ultra-fine biocompatible sutures. Monofilament sutures are commonly used for dural closure. These sutures maintain tissue integrity for a longer period of time as they are nonabsorbable. Microsurgical sutures with advancements such as antimicrobial coatings and improved elasticity are making it possible to be more precise during surgery and leading to better patient recovery, which makes them inevitable for delicate neurological procedures requiring cautious wound closure.

Analysis by End Use:

Hospitals
Ambulatory Surgical Centers and Clinics

Japan has a large network of hospitals managing a wide variety of complicated and critical cases, which form the main demand source for surgical sutures. Given the population is aging, along with increasing incidence of chronic diseases, advanced sutures for cardiovascular, orthopedic, and neurological surgery procedures are witnessing growth in demand. Hospitals also have a range of sutures they prefer-both absorbable and non-absorbable types. Technological advancements, such as tensile strength and antimicrobial coatings, are driving individuals to adopt sutures. Moreover, government healthcare initiatives as well as the improvement in surgical techniques increase demand for a high-quality suture in hospitals.

Ambulatory surgical centers (ASCs) and clinics are increasingly favored in Japan for their economical and efficient surgical options. These establishments are undertaking a rising volume of minimally invasive procedures, which in turn heightens the demand for precision sutures that facilitate expedited healing. ASCs generally utilize absorbable sutures for outpatient surgeries, thereby minimizing the necessity for subsequent removal. The growing inclination towards day-care surgeries, along with advancements in suture technology, is propelling demand in this sector. Furthermore, the transition towards outpatient care has bolstered the use of sutures engineered for faster recovery and diminished post-surgical complications.

Competitive Landscape:

The industry is highly characterized by intense research and development activities, strategic partnerships, and innovations in products. Leading Japanese manufacturers are focusing on developing advanced sutures with advanced tensile strength, biocompatibility, and antimicrobial properties, which should respond to the current demand for even more efficient and safe wound closure. Companies currently invest in the development of biodegradable and drug-eluting sutures to further reduce post-operative complications and guarantee better healing outcomes. Key participants are also looking to expand the distribution channels along with partnerships with hospitals and other surgical facilities, thereby enhancing the market presence. Innovations in technology, including smart sutures and materials compatible with robotic systems, are influencing competitive dynamics.

The report provides a comprehensive analysis of the competitive landscape in the Japan surgical sutures market with detailed profiles of all major companies.

Latest News and Developments:

January 07, 2025: Kaken Pharmaceutical of Japan entered into a licensing agreement valued at USD 1.2 Billion with Johnson & Johnson for the worldwide development, production, and marketing of its STAT6 inhibitor program, which encompasses KP-723. Kaken is responsible for concluding Phase I trials before Johnson & Johnson assumes control of global clinical development, while Kaken will maintain commercialization rights within Japan. The agreement features an initial payment of USD 30 Million, milestone-related payments that could reach up to USD 1.2175 Billion, along with royalties on international sales.
October 16, 2023: Japan's Gunze Limited announced allocating 3.5 billion JPY for the construction of a third medical facility and the expansion of its research and development laboratory in Ayabe, Kyoto, with a target completion date of February 2025. This initiative aims to strengthen its medical sector. The new plant will facilitate increased production of TENALEAF(TM), an absorbable surgical adhesive barrier, while also enhancing research and development efforts for next-generation products.

Key Questions Answered in This Report

1.How big is the surgical sutures market in Japan?
2.What factors are driving the growth of the Japan surgical sutures market?
3.What is the forecast for the surgical sutures market in Japan?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Surgical Sutures Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Surgical Sutures Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Surgical Sutures Market - Breakup by Type

6.1 Absorbable
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Nonabsorbable
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Surgical Sutures Market - Breakup by Filament

7.1 Monovalent
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Multivalent
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Surgical Sutures Market - Breakup by Application

8.1 Ophthalmic Surgery
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Cardiovascular Surgery
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Orthopedic Surgery
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Neurological Surgery
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Surgical Sutures Market - Breakup by End Use

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Ambulatory Surgical Centers and Clinics
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)

10 Japan Surgical Sutures Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
11.6 Company F
- 11.6.1 Business Overview
- 11.6.2 Product Portfolio
- 11.6.3 Business Strategies
- 11.6.4 SWOT Analysis
- 11.6.5 Major News and Events
11.7 Company G
- 11.7.1 Business Overview
- 11.7.2 Product Portfolio
- 11.7.3 Business Strategies
- 11.7.4 SWOT Analysis
- 11.7.5 Major News and Events
11.8 Company H
- 11.8.1 Business Overview
- 11.8.2 Product Portfolio
- 11.8.3 Business Strategies
- 11.8.4 SWOT Analysis
- 11.8.5 Major News and Events
11.9 Company I
- 11.9.1 Business Overview
- 11.9.2 Product Portfolio
- 11.9.3 Business Strategies
- 11.9.4 SWOT Analysis
- 11.9.5 Major News and Events
11.10 Company J
- 11.10.1 Business Overview
- 11.10.2 Product Portfolio
- 11.10.3 Business Strategies
- 11.10.4 SWOT Analysis
- 11.10.5 Major News and Events

12 Japan Surgical Sutures Market - Industry Analysis

12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis